Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVitamin B12 injections are sometimes promoted alongside weight-loss programmes, but the evidence that B12 itself causes weight loss is limited — and, like any injection, they carry side effects worth knowing about before you start. Pain or redness at the injection site, headache, nausea and, occasionally, dizziness are the most commonly reported reactions. They are usually mild and brief, but rare serious effects do exist and are worth taking seriously. This page covers what the research and clinical experience tell us about vitamin B12 injections and weight loss side effects, when symptoms need urgent medical attention, and how the licensed GLP-1 medicines that do have robust weight-loss evidence compare on the safety front.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most frequently reported side effects of vitamin B12 injections are local to the injection site: a sting during administration, followed by redness, mild swelling or a small lump that generally resolves within 24 to 48 hours. These reactions are common to almost any subcutaneous or intramuscular injection and say little about B12 specifically.
Beyond the site itself, some people report headache, a feeling of warmth or flushing, mild nausea, or dizziness shortly after the injection. These tend to pass within a few hours. Less commonly, diarrhoea and generalised itching have been noted in clinical literature. The NHS medicines information pages note that hydroxocobalamin (the form used medically for B12 deficiency) can cause acne-like skin reactions, and that high doses may very occasionally discolour the urine a deeper yellow, which is harmless.
One quick self-check is worth building into your routine: before each injection, inspect the skin area you plan to use. Any unresolved lump, persistent redness or broken skin from a previous injection means choosing a different site that day. That 30-second habit reduces the chance of localised irritation compounding over time. For a closer look at the side effects specific to B12 injections for weight loss, that page goes into further detail, and for broader context on what injection-based treatments involve, the side effects of weight-loss injections page covers the licensed GLP-1 medicines in more detail.
None of the effects above are unique to weight-loss use. The same profile applies when B12 is given for confirmed deficiency. The key difference is that deficiency treatment has a clear clinical rationale backed by BNF-listed dosing schedules; weight-loss use does not carry that same regulatory grounding in the UK.
Most side effects after a vitamin B12 injection are self-limiting. A few are not, and it matters to know the difference.
Get emergency help (call 999 or go to A&E) if you develop any of the following after an injection: swelling of the face, lips or throat; difficulty breathing or swallowing; a rapid or irregular heartbeat; collapse or severe dizziness that does not pass quickly; or a widespread rash across your body. These are signs of a serious allergic reaction (anaphylaxis). It is uncommon, but it can occur with any injected substance.
See a GP or NHS 111 promptly if you notice: an injection site that becomes hot, increasingly swollen or produces discharge over several days (signs of localised infection); persistent severe headache after the injection; or any neurological symptom such as tingling, numbness or visual disturbance that begins or worsens after starting injections. Polycythaemia (an overproduction of red blood cells) is a theoretical risk with very high-dose B12 over extended periods, though clinical cases linked to injections are rare.
If you experience anything unexpected, you or your clinician can report it through the MHRA Yellow Card scheme. That applies whether the injection came from a clinic, a GP or a private provider. Reporting genuinely improves the safety evidence base for everyone.
Our prescribers at nume discuss the full side-effect profile of any treatment during your consultation, including licensed weight-loss options. You can read more about how that process works on our about us page.
This is the question underneath most people's search. The honest answer is: the evidence that vitamin B12 injections drive meaningful weight loss in people who are not B12-deficient is thin. B12 plays an essential role in energy metabolism and red blood cell production, and deficiency can cause fatigue that makes activity harder, so correcting a genuine shortfall can improve energy levels. But correcting a deficiency is not the same as stimulating fat loss.
No large-scale, peer-reviewed trial has demonstrated that B12 injections cause clinically significant weight reduction in people with normal B12 levels. Weight-loss clinics that include them often combine B12 with other compounds (lipotropic injections, for instance), making it difficult to attribute any outcome to B12 alone. The NHS healthy weight guidance does not list B12 injections as a weight-management intervention.
With repeated injections the safety picture is mostly reassuring for the injection itself, B12 is water-soluble, so the body excretes what it cannot use rather than accumulating it to toxic levels. The greater concern with frequent clinic-based injections is the quality of the product, the sterility of administration, and the cumulative injection-site burden. Anyone using these treatments repeatedly should ensure the provider is regulated and uses pharmaceutical-grade product.
If you are looking for what B12 injections genuinely offer for weight loss, that page examines the evidence in full. For licensed, evidence-based treatment, our weight-loss injections page sets out what is available through a GPhC-registered pharmacy like ours, and if you are based in the Channel Islands, our page on weight loss injections in Guernsey covers what is available to you there.
Licensed GLP-1 receptor agonist medicines (tirzepatide (Mounjaro) and semaglutide (Wegovy)) are the injections with robust clinical trial evidence for weight loss in the UK. Their side-effect profile is quite different from B12 and worth comparing honestly.
GLP-1 medicines primarily cause gastrointestinal effects: nausea, constipation, loose stools, reflux and reduced appetite are common, particularly in the first weeks of treatment or after a dose increase. These are well-documented and, for most people, settle as the body adjusts. Injection-site reactions occur but are generally mild. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk: severe stomach pain that reaches through to the back, with or without vomiting, warrants urgent medical attention. The MHRA's guidance is clear that these medicines should only be used under clinical supervision.
B12 injections, by contrast, have a shorter gastrointestinal side-effect list but also carry none of the weight-loss evidence. A full comparison of what to expect from the licensed options is available on our weight-loss injection guide. If you are weighing up different approaches, speak to our prescribers, suitability and side effects are discussed as part of every consultation at no charge.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.